Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Loss of personal independence in daily activities, Memory impairment, Migraine, Nausea, Nervous system injury
Clinical narrative: Hashimoto's disease/autoimmune injury/autoimmune disorder/ autoimmune complications/memory issues/fatigue/thyroid issues; hypothyroidism/memory issues/ fatigue/thyroid issues; Polycystic ovary syndrome (PCOS)/amenorrhea/fatigue/fertility complications; cysts; tachycardia; four painful miscarriages/atypical abdomen pain; liver disease/liver pain/gastrointestinal problems/atypical abdomen pain/nausea; migraines; hypoglycemia; Neurological Injuries; autonomic injuries; heart palpitations; This retrospective pregnancy report has been received from a lawyer regarding a case in litigation and refers to an adult pregnant female patient (exact age was not provided). The patient was a healthy, physically active, and athletic teenager. Her medical history and concomitant therapies were not provided. On an unknown date, at the age of 13 years old, the patient was vaccinated with the first dose of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) intramuscular injection (exact dose, route of administration, anatomical location, lot # and expiration date were not provided), as recommended by her physician. On unknown dates, she was administered the second and the third dose of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) intramuscular injection (exact doses, routes of administration, anatomical locations, lot # and expiration dates were not provided). On unknown dates, the patient experienced serious and debilitating injuries, including but not limited to autoimmune, autonomic, fertility complications, and neurological injuries and resulting sequalae. On an unknown date, reported as after receiving Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL), the patient experienced fatigue, atypical abdomen pain, cysts, migraines, and nausea. She also experienced liver pain, gastrointestinal problems, heart palpitations, thyroid issues, amenorrhea, and memory issues. She was seen by multiple physicians and specialists for her complaints. On unknown dates, the patient became pregnant. The last menstrual period (LMP) and estimated delivery date (EDD) were not reported for all pregnancies. The pregnancy outcome was considered as a spontaneous abortion. The patient suffered four painful miscarriages by the age of 23. The first time the patient discovered that her injuries could be caused by Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) was in March 2021. It was then that the patient's mother encountered an article, which led her to a website discussing vaccine's risk. As a result of her post-Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) symptoms, the patient was unable to engage in activities that a young person her age would normally enjoy. She suffered pain and unbearable symptoms which made it difficult to function. Her academic performance suffered because of her symptoms, and she was stripped of her hopes to create a family. Based upon her chronic and severe post-Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) symptoms, the patient was diagnosed with various medical conditions, including but not limited to PCOS, Hashimoto's disease, liver disease, migraines, hypothyroidism, tachycardia, hypoglycemia, and four miscarriages before the age of 23. The patient experienced serious and debilitating autoimmune and neurological injuries, including but not limited to PCOS, Hashimoto's disease, liver disease, migraines, hypothyroidism, tachycardia, and hypoglycemia, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which were alleged herein and all of which were caused by Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) or otherwise linked to her Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL)-induced autoimmune disorder.As a proximate result of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL), the patient suffered and continued to suffer severe and permanent physical injuries, and associated symptomology and suffered severe and permanent emotional injuries, including pain and suffering. She also had a substantial fear of suffering additional and ongoing harms, including but not limited to then being at an increased risk of cancer, and future symptoms and harms associated with her injuries caused by Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL). As a direct and proximate result of her Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL)-induced injuries, the patient suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and she would continue to incur these losses and expenses in the future. The outcome of the events was considered to be not recovered. The reporter considered all events to be related to quadrivalent human papillomavirus (Types 6,11,16,18) recomb. vaccine (GARDASIL).   Upon internal review, the events of Hashimoto's disease, hypothyroidism, PCOS and miscarriages were determined to be medically significant. The reporter considered all events to be disabling.